Johnson seeking Senate vote on federal right-to-try bill

14:27 EDT 22 Sep 2016 | BioCentury

At a committee hearing Thursday, Sen. Ron Johnson (R-Wis.) said he plans to ask the U.S. Senate next week to approve the Trickett Wendler Right to Try Act of 2016 (S. 2912) under a unanimous consent request. The U.S. Senate Committee on Homeland Security and Governmental Affairs held the hearing to discuss the bill, which Johnson introduced in May. Johnson is the committee's chairman.

Johnson's bill would prohibit the federal government from limiting access of terminally ill patients to experimental treatments or devices, and would prohibit federal agencies from using those patients' outcomes to delay or deny the drugs' or devices' approval. The bill defines experimental products as those that have completed a Phase I trial and remain in clinical testing.

The Trickett Wendler Act now has 39 co-sponsors, including two Democrats, Joe Manchin (W.Va.) and Joe Donnelly (Ind.).

The health subcommittee of the U.S. House Energy and Commerce Committee is to hold a hearing Sept. 27 concerning expanded access to investigational therapies.

Original Article: Johnson seeking Senate vote on federal right-to-try bill


More From BioPortfolio on "Johnson seeking Senate vote on federal right-to-try bill"

Quick Search

Relevant Topics

Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...